ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 2390488

Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma.

Gioanni J and 7 others. Br J Cancer, 1990. Cited by 88 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. Papers, record 2390488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2390488

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma.
PubMed
Journal
Br J Cancer
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
1.67
iCite
Revised in PubMed
2019-05-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gioanni JJ
2Le François DD
3Zanghellini EE
4Mazeau CC
5Ettore FF
6Lambert JCJ C
7Schneider MM
8Dutrillaux BB

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Breast NeoplasmsMajor topic
Cell LineMajor topic
Chromosomes, HumanMajor topic
Adult
Animals
Chromosome Banding
Female
Humans
Karyotyping
Mice
Microscopy, Electron
Tumor Cells, Cultured

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,971,380Differential characteristics of two newly established human breast carcinoma cell lines.Cancer Res1985https://conductscience.org/library/papers/3971380PubMed
26,231,097Karyotypic progression in human tumors.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6231097PubMed
36,534,930Establishment and characterization of new cell line (YMB-1) derived from human breast carcinoma.Hiroshima J Med Sci1984https://conductscience.org/library/papers/6534930PubMed
43,896,352Cytogenetic and molecular biologic alterations in human breast cancer: a review.Breast Cancer Res Treat1985https://conductscience.org/library/papers/3896352PubMed
53,469,005Cytogenetic studies on human breast carcinomas.Breast Cancer Res Treat1986https://conductscience.org/library/papers/3469005PubMed
63,031,679Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3031679PubMed
73,499,851Cytogenetic study of twelve human near-diploid breast cancers with chromosomal changes.Ann Genet1987https://conductscience.org/library/papers/3499851PubMed
82,824,520Establishment and characterization of a new cell line (VHB-1) derived from a primary breast carcinoma.J Cancer Res Clin Oncol1987https://conductscience.org/library/papers/2824520PubMed
104,104,656[A new technic of analysis of the human karyotype].C R Acad Hebd Seances Acad Sci D1971https://conductscience.org/library/papers/4104656PubMed
114,357,757A human cell line from a pleural effusion derived from a breast carcinoma.J Natl Cancer Inst1973https://conductscience.org/library/papers/4357757PubMed

1 to 10 of 16

See all 16 references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
41,461,910p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism.Nat Genet2026https://conductscience.org/library/papers/41461910PubMed
40,790,603Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K.Breast Cancer Res2025https://conductscience.org/library/papers/40790603PubMed
39,068,572Cytotoxic Effect of Phoenix dactylifera (Iraqi Date) Leaves and Fruits Extracts against Breast Cancers Cell Lines.Asian Pac J Cancer Prev2024https://conductscience.org/library/papers/39068572PubMed
39,060,878Failure to progress: breast and prostate cancer cell lines in developing targeted therapies.Cancer Metastasis Rev2024https://conductscience.org/library/papers/39060878PubMed
38,391,914Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes.Cells2024https://conductscience.org/library/papers/38391914PubMed
38,310,186Antibodies toward Na+,HCO3--cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer.Br J Cancer2024https://conductscience.org/library/papers/38310186PubMed
36,763,142Chromosomal radiosensitivity of human breast carcinoma cells and blood lymphocytes following photon and proton exposures.Radiat Environ Biophys2023https://conductscience.org/library/papers/36763142PubMed
34,465,782Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes.Nat Commun2021https://conductscience.org/library/papers/34465782PubMed
31,218,111Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance.Am J Cancer Res2019https://conductscience.org/library/papers/31218111PubMed
29,158,785Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.J Cancer2017https://conductscience.org/library/papers/29158785PubMed

1 to 10 of 32

See all 32 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2390488

GET https://conductscience.org/api/papers/v1/2390488/cited_by?page=2

API referenceFor AI assistants